Dual Prevention Pill

DRUG2 trials

Sponsors

Population Council

Conditions

ContraceptionHIV Infections

Unknown Phase

A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

Active, not recruitingNCT04778527

Population CouncilHIV Infections

Start: 2022-09-13End: 2024-01-31Updated: 2024-02-06

A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

CompletedNCT04778514

Population CouncilContraception, HIV Infections

Start: 2022-12-07End: 2023-09-11Updated: 2024-02-06

Related Papers

Adherence, Preference, and Acceptability of an Overencapsulated Dual Prevention Pill for HIV and Pregnancy Prevention Among Women in Johannesburg, South Africa.

2026-02-01

A Dual Prevention Pill for HIV & Pregnancy Prevention: A Pilot Study Among Adolescent Girls and Young Women in Zimbabwe.

2025-11-18

Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe

BMJ Open2024-03-015 citations